nodes	percent_of_prediction	percent_of_DWPC	metapath
Lercanidipine—CYP3A7—Rifampicin—leprosy	0.137	0.158	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Rifampicin—leprosy	0.137	0.158	CbGbCtD
Lercanidipine—CYP3A7—Dapsone—leprosy	0.113	0.13	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Dapsone—leprosy	0.113	0.13	CbGbCtD
Lercanidipine—CYP3A5—Thalidomide—leprosy	0.106	0.122	CbGbCtD
Lercanidipine—CYP3A5—Rifampicin—leprosy	0.103	0.119	CbGbCtD
Lercanidipine—CYP3A5—Dapsone—leprosy	0.0851	0.0979	CbGbCtD
Lercanidipine—CYP3A4—Rifampicin—leprosy	0.0402	0.0462	CbGbCtD
Lercanidipine—CYP3A4—Dapsone—leprosy	0.0332	0.0382	CbGbCtD
Lercanidipine—Autoimmune disorder—Thalidomide—leprosy	0.00446	0.0341	CcSEcCtD
Lercanidipine—Proteinuria—Dapsone—leprosy	0.00331	0.0253	CcSEcCtD
Lercanidipine—Protein urine present—Dapsone—leprosy	0.00326	0.025	CcSEcCtD
Lercanidipine—Aphthous stomatitis—Thalidomide—leprosy	0.00317	0.0243	CcSEcCtD
Lercanidipine—Foetor hepaticus—Thalidomide—leprosy	0.00262	0.0201	CcSEcCtD
Lercanidipine—Serum creatinine increased—Thalidomide—leprosy	0.00242	0.0185	CcSEcCtD
Lercanidipine—Liver disorder—Thalidomide—leprosy	0.00218	0.0167	CcSEcCtD
Lercanidipine—Cholestasis—Thalidomide—leprosy	0.00196	0.015	CcSEcCtD
Lercanidipine—Nasopharyngitis—Dapsone—leprosy	0.00189	0.0144	CcSEcCtD
Lercanidipine—Muscular weakness—Dapsone—leprosy	0.00186	0.0142	CcSEcCtD
Lercanidipine—Pancreatitis—Dapsone—leprosy	0.00179	0.0137	CcSEcCtD
Lercanidipine—Proteinuria—Thalidomide—leprosy	0.00169	0.013	CcSEcCtD
Lercanidipine—Protein urine present—Thalidomide—leprosy	0.00167	0.0128	CcSEcCtD
Lercanidipine—Photosensitivity reaction—Dapsone—leprosy	0.00166	0.0127	CcSEcCtD
Lercanidipine—Oliguria—Thalidomide—leprosy	0.00161	0.0124	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Dapsone—leprosy	0.00159	0.0122	CcSEcCtD
Lercanidipine—Leukocytosis—Thalidomide—leprosy	0.00158	0.0121	CcSEcCtD
Lercanidipine—Hypercholesterolaemia—Thalidomide—leprosy	0.00157	0.012	CcSEcCtD
Lercanidipine—Hepatocellular injury—Thalidomide—leprosy	0.00149	0.0114	CcSEcCtD
Lercanidipine—Hyperkalaemia—Thalidomide—leprosy	0.00146	0.0112	CcSEcCtD
Lercanidipine—Blood urea increased—Thalidomide—leprosy	0.0014	0.0108	CcSEcCtD
Lercanidipine—Cramps of lower extremities—Thalidomide—leprosy	0.00137	0.0105	CcSEcCtD
Lercanidipine—Tinnitus—Dapsone—leprosy	0.00136	0.0104	CcSEcCtD
Lercanidipine—Gynaecomastia—Thalidomide—leprosy	0.00133	0.0102	CcSEcCtD
Lercanidipine—Erythema—Dapsone—leprosy	0.00127	0.00973	CcSEcCtD
Lercanidipine—Lymphadenopathy—Thalidomide—leprosy	0.00127	0.00969	CcSEcCtD
Lercanidipine—Diabetes mellitus—Thalidomide—leprosy	0.00124	0.00951	CcSEcCtD
Lercanidipine—Photosensitivity—Thalidomide—leprosy	0.00123	0.00942	CcSEcCtD
Lercanidipine—Vision blurred—Dapsone—leprosy	0.0012	0.00917	CcSEcCtD
Lercanidipine—Dermatitis exfoliative—Thalidomide—leprosy	0.00114	0.00876	CcSEcCtD
Lercanidipine—Vertigo—Dapsone—leprosy	0.00114	0.00874	CcSEcCtD
Lercanidipine—Arthritis—Thalidomide—leprosy	0.00111	0.00851	CcSEcCtD
Lercanidipine—Cough—Dapsone—leprosy	0.00111	0.00849	CcSEcCtD
Lercanidipine—Hypoglycaemia—Thalidomide—leprosy	0.00111	0.00847	CcSEcCtD
Lercanidipine—Cardiac failure—Thalidomide—leprosy	0.00111	0.00847	CcSEcCtD
Lercanidipine—Cerebrovascular accident—Thalidomide—leprosy	0.0011	0.00844	CcSEcCtD
Lercanidipine—Hyponatraemia—Thalidomide—leprosy	0.00108	0.0083	CcSEcCtD
Lercanidipine—Migraine—Thalidomide—leprosy	0.00106	0.00814	CcSEcCtD
Lercanidipine—Face oedema—Thalidomide—leprosy	0.00104	0.00798	CcSEcCtD
Lercanidipine—Tachycardia—Dapsone—leprosy	0.00101	0.00775	CcSEcCtD
Lercanidipine—Blood creatinine increased—Thalidomide—leprosy	0.00101	0.00775	CcSEcCtD
Lercanidipine—Orthostatic hypotension—Thalidomide—leprosy	0.000986	0.00755	CcSEcCtD
Lercanidipine—Breast disorder—Thalidomide—leprosy	0.000976	0.00747	CcSEcCtD
Lercanidipine—Cramp muscle—Thalidomide—leprosy	0.000972	0.00745	CcSEcCtD
Lercanidipine—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000972	0.00745	CcSEcCtD
Lercanidipine—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000972	0.00745	CcSEcCtD
Lercanidipine—Muscular weakness—Thalidomide—leprosy	0.000952	0.00729	CcSEcCtD
Lercanidipine—Alanine aminotransferase increased—Thalidomide—leprosy	0.000952	0.00729	CcSEcCtD
Lercanidipine—Insomnia—Dapsone—leprosy	0.000938	0.00718	CcSEcCtD
Lercanidipine—Bronchospasm—Thalidomide—leprosy	0.000918	0.00703	CcSEcCtD
Lercanidipine—Pancreatitis—Thalidomide—leprosy	0.000915	0.00701	CcSEcCtD
Lercanidipine—Angina pectoris—Thalidomide—leprosy	0.000909	0.00696	CcSEcCtD
Lercanidipine—Pancytopenia—Thalidomide—leprosy	0.000886	0.00679	CcSEcCtD
Lercanidipine—Neutropenia—Thalidomide—leprosy	0.000873	0.00668	CcSEcCtD
Lercanidipine—Pollakiuria—Thalidomide—leprosy	0.000862	0.0066	CcSEcCtD
Lercanidipine—Erectile dysfunction—Thalidomide—leprosy	0.00086	0.00658	CcSEcCtD
Lercanidipine—Photosensitivity reaction—Thalidomide—leprosy	0.000852	0.00652	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Dapsone—leprosy	0.000848	0.00649	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000825	0.00632	CcSEcCtD
Lercanidipine—Acute coronary syndrome—Thalidomide—leprosy	0.00082	0.00628	CcSEcCtD
Lercanidipine—Body temperature increased—Dapsone—leprosy	0.00082	0.00628	CcSEcCtD
Lercanidipine—Abdominal pain—Dapsone—leprosy	0.00082	0.00628	CcSEcCtD
Lercanidipine—Renal failure—Thalidomide—leprosy	0.000818	0.00626	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Thalidomide—leprosy	0.000816	0.00625	CcSEcCtD
Lercanidipine—Myocardial infarction—Thalidomide—leprosy	0.000816	0.00625	CcSEcCtD
Lercanidipine—Stomatitis—Thalidomide—leprosy	0.000811	0.00621	CcSEcCtD
Lercanidipine—Agranulocytosis—Thalidomide—leprosy	0.000777	0.00595	CcSEcCtD
Lercanidipine—Rhinitis—Thalidomide—leprosy	0.000749	0.00574	CcSEcCtD
Lercanidipine—Hepatitis—Thalidomide—leprosy	0.000747	0.00572	CcSEcCtD
Lercanidipine—Urinary tract disorder—Thalidomide—leprosy	0.000738	0.00565	CcSEcCtD
Lercanidipine—Oedema peripheral—Thalidomide—leprosy	0.000736	0.00564	CcSEcCtD
Lercanidipine—Urethral disorder—Thalidomide—leprosy	0.000732	0.00561	CcSEcCtD
Lercanidipine—Erythema multiforme—Thalidomide—leprosy	0.000706	0.00541	CcSEcCtD
Lercanidipine—Eye disorder—Thalidomide—leprosy	0.000698	0.00535	CcSEcCtD
Lercanidipine—Tinnitus—Thalidomide—leprosy	0.000697	0.00533	CcSEcCtD
Lercanidipine—Cardiac disorder—Thalidomide—leprosy	0.000693	0.00531	CcSEcCtD
Lercanidipine—Angiopathy—Thalidomide—leprosy	0.000678	0.00519	CcSEcCtD
Lercanidipine—Immune system disorder—Thalidomide—leprosy	0.000675	0.00517	CcSEcCtD
Lercanidipine—Mediastinal disorder—Thalidomide—leprosy	0.000673	0.00516	CcSEcCtD
Lercanidipine—Alopecia—Thalidomide—leprosy	0.00066	0.00506	CcSEcCtD
Lercanidipine—Vomiting—Dapsone—leprosy	0.000659	0.00505	CcSEcCtD
Lercanidipine—Mental disorder—Thalidomide—leprosy	0.000655	0.00501	CcSEcCtD
Lercanidipine—Malnutrition—Thalidomide—leprosy	0.00065	0.00498	CcSEcCtD
Lercanidipine—Headache—Dapsone—leprosy	0.00065	0.00497	CcSEcCtD
Lercanidipine—Tension—Thalidomide—leprosy	0.000638	0.00489	CcSEcCtD
Lercanidipine—Dysgeusia—Thalidomide—leprosy	0.000637	0.00488	CcSEcCtD
Lercanidipine—Nervousness—Thalidomide—leprosy	0.000632	0.00484	CcSEcCtD
Lercanidipine—Muscle spasms—Thalidomide—leprosy	0.000625	0.00479	CcSEcCtD
Lercanidipine—Nausea—Dapsone—leprosy	0.000616	0.00472	CcSEcCtD
Lercanidipine—Vision blurred—Thalidomide—leprosy	0.000613	0.00469	CcSEcCtD
Lercanidipine—Ill-defined disorder—Thalidomide—leprosy	0.000603	0.00462	CcSEcCtD
Lercanidipine—Anaemia—Thalidomide—leprosy	0.000601	0.0046	CcSEcCtD
Lercanidipine—Angioedema—Thalidomide—leprosy	0.000594	0.00455	CcSEcCtD
Lercanidipine—Malaise—Thalidomide—leprosy	0.000586	0.00449	CcSEcCtD
Lercanidipine—Vertigo—Thalidomide—leprosy	0.000584	0.00447	CcSEcCtD
Lercanidipine—Syncope—Thalidomide—leprosy	0.000583	0.00447	CcSEcCtD
Lercanidipine—Palpitations—Thalidomide—leprosy	0.000575	0.0044	CcSEcCtD
Lercanidipine—Loss of consciousness—Thalidomide—leprosy	0.000572	0.00438	CcSEcCtD
Lercanidipine—Cough—Thalidomide—leprosy	0.000567	0.00435	CcSEcCtD
Lercanidipine—Myalgia—Thalidomide—leprosy	0.000554	0.00424	CcSEcCtD
Lercanidipine—Chest pain—Thalidomide—leprosy	0.000554	0.00424	CcSEcCtD
Lercanidipine—Arthralgia—Thalidomide—leprosy	0.000554	0.00424	CcSEcCtD
Lercanidipine—Anxiety—Thalidomide—leprosy	0.000552	0.00423	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00055	0.00421	CcSEcCtD
Lercanidipine—Discomfort—Thalidomide—leprosy	0.000547	0.00419	CcSEcCtD
Lercanidipine—Dry mouth—Thalidomide—leprosy	0.000541	0.00415	CcSEcCtD
Lercanidipine—Confusional state—Thalidomide—leprosy	0.000535	0.0041	CcSEcCtD
Lercanidipine—Shock—Thalidomide—leprosy	0.000522	0.004	CcSEcCtD
Lercanidipine—Nervous system disorder—Thalidomide—leprosy	0.000521	0.00399	CcSEcCtD
Lercanidipine—Thrombocytopenia—Thalidomide—leprosy	0.00052	0.00398	CcSEcCtD
Lercanidipine—Tachycardia—Thalidomide—leprosy	0.000518	0.00397	CcSEcCtD
Lercanidipine—Skin disorder—Thalidomide—leprosy	0.000516	0.00395	CcSEcCtD
Lercanidipine—Hyperhidrosis—Thalidomide—leprosy	0.000513	0.00393	CcSEcCtD
Lercanidipine—Anorexia—Thalidomide—leprosy	0.000506	0.00387	CcSEcCtD
Lercanidipine—Hypotension—Thalidomide—leprosy	0.000496	0.0038	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Thalidomide—leprosy	0.000484	0.0037	CcSEcCtD
Lercanidipine—Insomnia—Thalidomide—leprosy	0.00048	0.00368	CcSEcCtD
Lercanidipine—Paraesthesia—Thalidomide—leprosy	0.000477	0.00365	CcSEcCtD
Lercanidipine—Dyspnoea—Thalidomide—leprosy	0.000473	0.00362	CcSEcCtD
Lercanidipine—Somnolence—Thalidomide—leprosy	0.000472	0.00361	CcSEcCtD
Lercanidipine—Dyspepsia—Thalidomide—leprosy	0.000467	0.00358	CcSEcCtD
Lercanidipine—Decreased appetite—Thalidomide—leprosy	0.000461	0.00353	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Thalidomide—leprosy	0.000458	0.00351	CcSEcCtD
Lercanidipine—Fatigue—Thalidomide—leprosy	0.000458	0.0035	CcSEcCtD
Lercanidipine—Constipation—Thalidomide—leprosy	0.000454	0.00348	CcSEcCtD
Lercanidipine—Feeling abnormal—Thalidomide—leprosy	0.000437	0.00335	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Thalidomide—leprosy	0.000434	0.00332	CcSEcCtD
Lercanidipine—Urticaria—Thalidomide—leprosy	0.000422	0.00323	CcSEcCtD
Lercanidipine—Abdominal pain—Thalidomide—leprosy	0.00042	0.00321	CcSEcCtD
Lercanidipine—Body temperature increased—Thalidomide—leprosy	0.00042	0.00321	CcSEcCtD
Lercanidipine—Hypersensitivity—Thalidomide—leprosy	0.000391	0.00299	CcSEcCtD
Lercanidipine—Asthenia—Thalidomide—leprosy	0.000381	0.00292	CcSEcCtD
Lercanidipine—Pruritus—Thalidomide—leprosy	0.000376	0.00288	CcSEcCtD
Lercanidipine—Diarrhoea—Thalidomide—leprosy	0.000363	0.00278	CcSEcCtD
Lercanidipine—Dizziness—Thalidomide—leprosy	0.000351	0.00269	CcSEcCtD
Lercanidipine—Vomiting—Thalidomide—leprosy	0.000337	0.00258	CcSEcCtD
Lercanidipine—Rash—Thalidomide—leprosy	0.000335	0.00256	CcSEcCtD
Lercanidipine—Dermatitis—Thalidomide—leprosy	0.000334	0.00256	CcSEcCtD
Lercanidipine—Headache—Thalidomide—leprosy	0.000333	0.00255	CcSEcCtD
Lercanidipine—Nausea—Thalidomide—leprosy	0.000315	0.00241	CcSEcCtD
